Polycystic Ovary Syndrome: Semaglutide

Summary

To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of prescribing semiglutides on the NHS for patients with polycystic ovary syndrome.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 17 July 2024

   Written question

   To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of prescribing semiglutides on the NHS for patients with polycystic ovary syndrome.

   Source: Commons

2. 29 July 2024

   Answer

   While semaglutide is not licensed as a treatment option for polycystic ovary syndrome (PCOS), clinicians can prescribe medicines outside their licensed indication, known as off-label prescribing, where they consider it to be the best treatment option for ...

   Source: Written answer

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

• · Department of Health and Social Care · Answering body

Related records

No cross-record relationships stored yet.